FDFT1/FGFR2 rearrangement: A newly identified anlotinib-sensitive FGFR2 variant
- This topic has 0 replies, 1 voice, and was last updated 1 year, 12 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FDFT1/FGFR2 rearrangement: A newly identified anlotinib-sensitive FGFR2 variant in cholangiocarcinoma
https://pubmed.ncbi.nlm.nih.gov/35477128/
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.